Literature DB >> 10878292

Mechanisms of action of methotrexate.

L Genestier1, R Paillot, L Quemeneur, K Izeradjene, J P Revillard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10878292     DOI： 10.1016/s0162-3109(00)00189-2

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN： 0162-3109


× No keyword cloud information.
  49 in total

1.  Clinical analysis of chinese patients with rheumatoid arthritis treated with leflunomide and methotrexate combined with different dosages of glucocorticoid.

Authors:  Cong-Zhu Ding; Yao Yao; Xue-Bing Feng; Yun Fang; Cheng Zhao; Yue Wang
Journal:  Curr Ther Res Clin Exp       Date:  2012-09

2.  Case files of the New York City Poison Control Center: antidotal strategies for the management of methotrexate toxicity.

Authors:  Silas W Smith; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2008-06

3.  Protective effects of carvacrol and pomegranate against methotrexate-induced intestinal damage in rats.

Authors:  Gül Türkcü; Ulaş Alabalık; Ayşe Nur Keleş; Mehtap Bozkurt; İbrahim İbiloğlu; Uğur Fırat; Hüseyin Büyükbayram
Journal:  Int J Clin Exp Med       Date:  2015-09-15

4.  Copper-free click conjugation of methotrexate to a PAMAM dendrimer platform.

Authors:  Baohua Huang; Ankur Desai; Hong Zong; Shengzhuang Tang; Pascale Leroueil; James R Baker
Journal:  Tetrahedron Lett       Date:  2011-03-30       Impact factor: 2.415

5.  Association of the TYMS 3G/3G genotype with poor response and GGH 354GG genotype with the bone marrow toxicity of the methotrexate in RA patients.

Authors:  Biljana Jekic; Ljiljana Lukovic; Vera Bunjevacki; Vera Milic; Ivana Novakovic; Tatjana Damnjanovic; Jelena Milasin; Branka Popovic; Nela Maksimovic; Nemanja Damjanov; Goran Radunovic; Ljiljana Kovacevic; Maja Krajinovic
Journal:  Eur J Clin Pharmacol       Date:  2012-07-05       Impact factor: 2.953

6.  Polymorphisms of the eNOS gene are associated with disease activity in rheumatoid arthritis.

Authors:  Vera Bunjevacki; Nela Maksimovic; Biljana Jekic; Vera Milic; Ljiljana Lukovic; Ivana Novakovic; Nemanja Damjanov; Goran Radunovic; Tatjana Damnjanovic
Journal:  Rheumatol Int       Date:  2015-11-26       Impact factor: 2.631

7.  The influence of oxidative stress on symptom occurrence, severity, and distress during childhood leukemia treatment.

Authors:  Marilyn J Hockenberry; Olga A Taylor; Alice Pasvogel; Cheryl Rodgers; Kathy McCarthy; Patricia Gundy; David W Montgomery; Phillip Ribbeck; Michael E Scheurer; Ida M Ki Moore
Journal:  Oncol Nurs Forum       Date:  2014-07-01       Impact factor: 2.172

Review 8.  Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease.

Authors:  Emilio G Quetglas; Zlatan Mujagic; Simone Wigge; Daniel Keszthelyi; Sebastian Wachten; Ad Masclee; Walter Reinisch
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

Review 9.  Pharmacogenetics of methotrexate in acute lymphoblastic leukaemia: why still at the bench level?

Authors:  Sunitha Kodidela; Pradhan Suresh Chandra; Biswajit Dubashi
Journal:  Eur J Clin Pharmacol       Date:  2013-12-27       Impact factor: 2.953

10.  Fabrication of methotrexate-loaded gold nanoconjugates and its enhanced anticancer activity in breast cancer.

Authors:  Ramesh Chaudhari; Pal Patel; Nikita Meghani; Simran Nasra; Ashutosh Kumar
Journal:  3 Biotech       Date:  2021-03-18       Impact factor: 2.406
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.